Allogene Therapeutics ALLO Income Statement (2018-2026)

NASDAQ ALLO
$1.98 +0.00 (+0.00%)
As of: Sep 4, 2026 · 2:21 PM EDT
Reported Financials

Allogene Therapeutics Quarterly Income Statement

Periods 34 quarters
Latest Jun 2026

Allogene Therapeutics reported revenue of $4.64M and net income of -$43.01M for the quarter ended Jun 2026. This income statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
142.44M142.62M143.57M143.72M144.03M144.44M145.74M167.13M168.18M168.64M170.45M209.05M209.50M212.21M218.60M220.13M223.16M229.41M244.82M345.35M
Revenue & cost
Revenue
0.05M75.65M0.04M0.06M0.03M0.03M0.03M0.02M0.02M0.02M0.02M4.64M
Operating items
Research & DevelopmentR&D
58.72M53.98M60.16M57.17M63.64M75.42M80.24M62.04M45.98M54.66M52.26M50.35M44.71M44.97M50.20M40.16M31.16M28.63M32.00M30.72M
Selling, General & AdministrativeSG&A
19.00M19.96M19.90M19.51M18.90M21.00M18.88M18.52M17.04M17.22M17.27M16.09M16.33M15.52M14.99M14.28M13.74M13.77M14.09M20.84M
Other Operating ExpensesOther Opex
13.24M4.99M10.73M2.38M
Operating ExpensesOpex
77.72M73.94M80.05M76.68M82.54M96.42M99.12M80.56M63.02M85.13M69.53M71.43M71.77M60.49M65.19M56.82M44.90M42.40M46.09M51.56M
Operating IncomeOp. Inc
-77.67M1.71M-80.01M-76.62M-82.51M-96.39M-99.09M-80.54M-63.00M-85.11M-69.50M-71.43M-71.77M-60.49M-65.19M-56.82M-44.90M-42.40M-46.09M-46.92M
EBIT
-77.67M1.71M-80.01M-76.62M-82.51M-96.39M-99.09M-80.54M-63.00M-85.11M-69.50M-71.43M-71.77M-60.49M-65.19M-56.82M-44.90M-42.40M-46.09M-46.92M
Non-operating items
Non Operating Interest Expenses
0.91M1.16M0.35M2.94M-2.94M0.10M0.08M0.15M0.27M0.34M0.31M0.30M0.34M
Interest & Investment IncomeInt & Inv Inc
0.39M0.19M0.49M0.32M1.00M2.76M2.06M3.78M6.21M6.26M5.43M4.99M6.71M3.03M5.52M6.19M3.93M3.66M3.57M4.65M
Other Non Operating IncomeOther Non Op Inc.
-0.91M-1.81M0.92M-3.99M-2.73M-3.64M2.06M-2.47M-5.50M-6.93M-0.93M0.09M-1.12M-1.95M0.09M-0.04M-0.08M0.25M0.21M-0.06M
Non Operating IncomeNon Op. Inc.
-0.52M-1.62M1.41M-3.67M-1.73M-0.88M-0.88M1.31M0.71M-0.67M4.50M5.07M5.48M0.99M5.46M5.88M3.50M3.59M3.48M4.24M
Net income details
EBT
-78.19M0.73M-79.87M-76.30M-81.51M-93.64M-99.97M-76.76M-56.79M-75.91M-64.07M-66.44M-65.17M-57.54M-59.83M-50.90M-41.32M-39.06M-42.82M-42.62M
Tax ProvisionsTaxes
Profit After TaxPAT
-78.25M-2.08M-85.29M-82.51M-85.73M-94.24M-99.97M-79.23M-62.29M-85.78M-65.00M-66.36M-66.29M-59.94M-59.73M-51.03M-41.40M-38.81M-42.61M-43.01M
Income from Continuing OperationsIncome (Continuing)
-78.19M0.73M-79.87M-76.30M-81.51M-93.64M-99.97M-76.76M-56.79M-75.91M-64.07M-66.44M-65.17M-57.54M-59.83M-50.90M-41.32M-39.06M-42.82M-42.62M
Consolidated Net IncomeConsol Net Inc.
-78.19M0.73M-79.87M-76.30M-81.51M-93.64M-99.97M-76.76M-56.79M-75.91M-64.07M-66.44M-65.17M-57.54M-59.83M-50.90M-41.32M-39.06M-42.82M-42.62M
Income towards Parent CompanyParent Net Inc
-78.19M0.73M-79.87M-76.30M-81.51M-93.64M-99.97M-76.76M-56.79M-75.91M-64.07M-66.44M-65.17M-57.54M-59.83M-50.90M-41.32M-39.06M-42.82M-42.62M
Net Income towards Common StockholdersNet Income
-78.19M0.73M-79.87M-76.30M-81.51M-93.64M-99.97M-76.76M-56.79M-75.91M-64.07M-66.44M-65.17M-57.54M-59.83M-50.90M-41.32M-39.06M-42.82M-42.62M
Additional items
EPS (Basic)
-0.570.01-0.57-0.53-0.57-0.65-0.69-0.52-0.34-0.48-0.38-0.35-0.31-0.30-0.28-0.23-0.19-0.18-0.18-0.13
EPS (Diluted)
-0.570.01-0.57-0.53-0.57-0.65-0.69-0.52-0.34-0.48-0.38-0.35-0.31-0.30-0.28-0.23-0.19-0.18-0.18-0.13
Shares Outstanding
137.03M135.82M141.36M143.39M143.66M143.15M144.56M146.80M167.65M156.93M169.13M190.03M209.19M194.81M215.36M218.93M222.04M220.62M240.29M328.93M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
137.03M135.82M141.36M143.39M143.66M143.15M144.56M146.80M167.65M156.93M169.13M190.03M209.19M194.81M215.36M218.93M222.04M220.62M240.29M328.93M
EBITDA
-77.67M1.71M-80.01M-76.62M-82.51M-96.39M-99.09M-80.54M-63.00M-85.11M-69.50M-71.43M-71.77M-60.49M-65.19M-56.82M-44.90M-42.40M-46.09M-46.92M
Interest ExpensesInt Expense
0.91M1.16M0.35M2.94M-2.94M0.10M0.08M0.15M0.27M0.34M0.31M0.30M0.34M
Tax Rate